A Case of Postpartum Reversible Cerebral Vasoconstriction Syndrome / 대한내과학회지

Reversible cerebral vasoconstriction syndrome (RCVS) is characterized by development of a severe thunderclap headache with or without other acute neurological symptoms, and by multifocal or diffuse segmental vasoconstriction of the cerebral arteries that resolves spontaneously within 3 months. Several precipitating factors have been identified; these include the use of adrenergic or serotonergic drugs and postpartum status. Diagnosis is aided by the dynamic nature of the clinicoradiological features, including a 'beads-on-a-string' appearance of the cerebral arteries on angiography, and complete (or near-complete) resolution of the condition evident on repeat angiography performed 3 months after initial onset. Calcium channel blockers such as nimodipine seem to relieve the severe headache within 48 h. Here, we present the case of a female who developed RCVS postpartum.

Chronic urticaria treated with tacrolimus

Cyclosporine is a calcineurin inhibitor which is used to treat antihistamine-resistant chronic urticaria. Unfortunately, some patients cannot use cyclosporine due to its side effects. Tacrolimus is another calcineurin inhibitor with a slightly different side effect profile from that of cyclosporine, and a few cases of chronic urticaria have been treated with tacrolimus. Here, we report a patient with anti-histamine-resistant chronic urticaria, who could not be treated with cyclosporine, due to side effects, but was controlled successfully with tacrolimus. To the best of our knowledge, this is the first report of tacrolimus-treated chronic urticaria in Korea.

Correction: Extensive Intramuscular Venous Malformation in the Lower Extremity

We found that the first author name was published incorrectly. Jung Ho Chul was changed to Ho Chul Jung.

Induction of apoptosis by etoposide treatment in colon cancer cell line SNU C2A

No abstract available.